Your browser doesn't support javascript.
loading
Corrigendum to: "Circumventing drug resistance in gastric cancer: A spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics" [Drug Resist Updates 74 (2024) 101080].
Che, Gang; Yin, Jie; Wang, Wankun; Luo, Yandong; Chen, Yiran; Yu, Xiongfei; Wang, Haiyong; Liu, Xiaosun; Chen, Zhendong; Wang, Xing; Chen, Yu; Wang, Xujin; Tang, Kaicheng; Tang, Jiao; Shao, Wei; Wu, Chao; Sheng, Jianpeng; Li, Qing; Liu, Jian.
Afiliación
  • Che G; Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China.
  • Yin J; Department of Colorectal Medicine, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
  • Wang W; Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China.
  • Luo Y; Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.
  • Chen Y; Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China.
  • Yu X; Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China.
  • Wang H; Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China.
  • Liu X; Department of Gastrointestinal Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China.
  • Chen Z; Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China.
  • Wang X; Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China.
  • Chen Y; Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China.
  • Wang X; Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China.
  • Tang K; Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.
  • Tang J; College of Computer Science and Technology, Nanjing University of Aeronautics and Astronautics (NUAA), Nanjing 211106, China.
  • Shao W; College of Computer Science and Technology, Nanjing University of Aeronautics and Astronautics (NUAA), Nanjing 211106, China.
  • Wu C; Department of Medical Oncology, Senior Department of Oncology, Chinese PLA General Hospital, The Fifth Medical Center, Beijing 100853, China. Electronic address: wuchao@medmail.com.cn.
  • Sheng J; Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China; Center for Intelligent Oncology Designated by State Ministry of Education, Chongqing University, Chongqing 400030, China; Chongqing Key Laboratory
  • Li Q; College of Bioengineering, Chongqing University, Chongqing 400030, China. Electronic address: likunze88824@163.com.
  • Liu J; Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China. Electronic address: liujianzy@zju.edu.cn.
Drug Resist Updat ; 76: 101101, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38897903

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Drug Resist Updat Asunto de la revista: ANTINEOPLASICOS Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Drug Resist Updat Asunto de la revista: ANTINEOPLASICOS Año: 2024 Tipo del documento: Article